Aktis Oncology, Inc.
AKTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $37,159 | $29,513 | $128,597 |
| Short-Term Investments | $260,009 | $68,349 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $3,685 | $2,342 | $3,884 |
| Total Curr. Assets | $300,853 | $100,204 | $132,481 |
| Property Plant & Equip (Net) | $20,871 | $20,924 | $4,865 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $4,457 | $1,227 | $976 |
| Total NC Assets | $25,328 | $22,151 | $5,841 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $326,181 | $122,355 | $138,322 |
| Liabilities | – | – | – |
| Payables | $1,918 | $957 | $490 |
| Short-Term Debt | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $9,277 | $0 | $0 |
| Other Curr. Liab. | $3,084 | $2,033 | $1,194 |
| Total Curr. Liab. | $18,822 | $6,237 | $5,275 |
| LT Debt | $0 | $0 | $0 |
| Deferred Rev, NC | $51,039 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $333,409 | $150,550 | $151,356 |
| Total NC Liab. | $395,162 | $162,424 | $152,277 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $12,010 | $13,402 | $1,775 |
| Total Liabilities | $413,984 | $168,661 | $157,552 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$92,833 | -$48,853 | -$20,212 |
| AOCI | $124 | $82 | $0 |
| Other Equity | $0 | $0 | $0 |
| Total Equity | -$87,803 | -$46,306 | -$19,230 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $326,181 | $122,355 | $138,322 |
| Net Debt | -$37,159 | -$29,513 | -$128,597 |